Literature DB >> 31194545

Facile High-Performance Liquid Chromatography Mass Spectrometry Method for Analysis of Cyclocreatine and Phosphocyclocreatine in Complex Mixtures of Amino Acids.

Dingyin Tao1, William Leister1, Wenwei Huang1, Asaf Alimardanov1, Christopher A LeClair1.   

Abstract

Creatine transporter deficiency (CTD) is caused by a defect in the X-linked creatine transporter SLC6A8 gene leading to severe neurologic and physiologic conditions. Cyclocreatine and phosphocyclocreatine supplementation is seen as a potential treatment, but the presence of these compounds within commercially available dietary supplements presents the risk of self-medication. High-performance liquid chromatography-mass spectrometry (HPLC-MS) is an excellent technique to assess composition of complex amino acid mixtures. Herein, we have developed a facile HPLC-MS method using a cyano column in hydrophilic interaction liquid chromatography (HILIC) mode with isocratic elution over 4 min to identify the main components of two commercially available dietary supplements. The relative standard deviation (RSD) for retention time and extracted ion integrated area are <0.3% and 4%, respectively, showing excellent reproducibility. Cyclocreatine and phosphocyclocreatine were not detectable within the dietary supplements, even at ppm levels, demonstrating the power and importance of the developed HPLC-MS method in analyzing complex mixtures.

Entities:  

Keywords:  HILIC; HPLC-MS; creatine; creatine transporter deficiency; cyclocreatine; dietary supplement; phosphocyclocreatine

Mesh:

Substances:

Year:  2019        PMID: 31194545      PMCID: PMC7045947          DOI: 10.1021/acs.jafc.9b01878

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  22 in total

1.  A novel reversed-phase HPLC method for the determination of urinary creatinine by pre-column derivatization with ethyl chloroformate: comparative studies with the standard Jaffé and isotope-dilution mass spectrometric assays.

Authors:  Elvis M K Leung; Wan Chan
Journal:  Anal Bioanal Chem       Date:  2014-01-10       Impact factor: 4.142

2.  Quantification of cyclocreatine in mouse and rat plasma using hydrophilic-interaction ultra-performance liquid chromatography-tandem mass spectrometry.

Authors:  Amy Q Wang; Emma Hughes; Wenwei Huang; Edward H Kerns; Xin Xu
Journal:  J Pharm Biomed Anal       Date:  2017-07-31       Impact factor: 3.935

3.  Cyclocreatine phosphate as a substitute for creatine phosphate in vertebrate tissues. Energistic considerations.

Authors:  T M Annesley; J B Walker
Journal:  Biochem Biophys Res Commun       Date:  1977-01-10       Impact factor: 3.575

Review 4.  X-linked creatine transporter deficiency: clinical aspects and pathophysiology.

Authors:  Jiddeke M van de Kamp; Grazia M Mancini; Gajja S Salomons
Journal:  J Inherit Metab Dis       Date:  2014-05-01       Impact factor: 4.982

5.  Stable isotope dilution method for the determination of guanidinoacetic acid by gas chromatography/mass spectrometry.

Authors:  Ralph Fingerhut
Journal:  Rapid Commun Mass Spectrom       Date:  2003       Impact factor: 2.419

6.  Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency.

Authors:  Yuko Kurosawa; Ton J Degrauw; Diana M Lindquist; Victor M Blanco; Gail J Pyne-Geithman; Takiko Daikoku; James B Chambers; Stephen C Benoit; Joseph F Clark
Journal:  J Clin Invest       Date:  2012-07-02       Impact factor: 14.808

7.  Simultaneous determination of guanidinoacetate, creatine and creatinine in urine and plasma by un-derivatized liquid chromatography-tandem mass spectrometry.

Authors:  R S Carling; S L Hogg; T C Wood; J Calvin
Journal:  Ann Clin Biochem       Date:  2008-09-09       Impact factor: 2.057

Review 8.  X-linked creatine transporter defect: an overview.

Authors:  G S Salomons; S J M van Dooren; N M Verhoeven; D Marsden; C Schwartz; K M Cecil; T J DeGrauw; C Jakobs
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

9.  High-performance liquid chromatographic assays for free and phosphorylated derivatives of the creatine analogues beta-guanidopropionic acid and 1-carboxy-methyl-2-iminoimidazolidine (cyclocreatine).

Authors:  R W Wiseman; T S Moerland; P B Chase; R Stuppard; M J Kushmerick
Journal:  Anal Biochem       Date:  1992-08-01       Impact factor: 3.365

10.  Simultaneous determination of creatine phosphate, creatine and 12 nucleotides in rat heart by LC-MS/MS.

Authors:  Jun-mei Wang; Yang Chu; Wei Li; Xiang-yang Wang; Jia-hua Guo; Lu-lu Yan; Xiao-hui Ma; Ying-li Ma; Qi-hui Yin; Chang-xiao Liu
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-03-25       Impact factor: 3.205

View more
  2 in total

1.  Phosphocyclocreatine is the dominant form of cyclocreatine in control and creatine transporter deficiency patient fibroblasts.

Authors:  Kirill Gorshkov; Amy Q Wang; Wei Sun; Ethan Fisher; Marta Frigeni; Marc Singleton; Natasha Thorne; Bradley Class; Wenwei Huang; Nicola Longo; Minh-Ha T Do; Elizabeth A Ottinger; Xin Xu; Wei Zheng
Journal:  Pharmacol Res Perspect       Date:  2019-12

2.  Treatment experience in two adults with creatinfe transporter deficiency.

Authors:  Jack Schjelderup; Sigrun Hope; Christian Vatshelle; Clara D M van Karnebeek
Journal:  Mol Genet Metab Rep       Date:  2021-02-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.